Literature DB >> 7237901

Barbiturate and hypnosedative withdrawal by a multiple oral phenobarbital loading dose technique.

G M Robinson, E M Sellers, E Janecek.   

Abstract

Although intravenous phenobarbital loading is effective in barbiturate withdrawal, controlled infusions of a drug are inconvenient. To develop a practical and more widely applicable method, oral loading doses of phenobarbital were given to 21 barbiturate addicts, whose estimated mean daily intake of barbiturates was 1 gm (range 0.5 to 4 gm). Twelve had a past or present history of barbiturate withdrawal seizures. Phenobarbital was given orally at a rate of 120 mg/hr until a predetermined clinical end point of phenobarbital effect was achieved. This end point was the presence of at least three of the following: nystagmus, drowsiness, ataxia, dysarthria, or emotional lability. The total phenobarbital loading dose (mean +/- SD) was 23.4 +/- 7.1 mg/kg, median phenobarbital concentration after loading was 35.9 mg/l (range 13.2 to 71.6 mg/l), and median half-life (t 1/2) of phenobarbital was 90 hr (range 38 to 240 hr). One patient with t 1/2 = 38 hr was given supplemental doses of phenobarbital. None developed seizures or other evidence of barbiturate withdrawal.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7237901     DOI: 10.1038/clpt.1981.129

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  14 in total

Review 1.  Clinical issues related to the costs of alcoholism.

Authors:  M O Howard; R W McGuffin; A J Saxon; K L Sloan; R D Walker
Journal:  Pharmacoeconomics       Date:  1996-02       Impact factor: 4.981

2.  Oral phenobarbital loading: a safe method of barbiturate and nonbarbiturate hypnosedative withdrawal.

Authors:  E Janecek; B M Kapur; P Devenyi
Journal:  CMAJ       Date:  1987-09-01       Impact factor: 8.262

Review 3.  Pharmacokinetic determinants of drug abuse and dependence. A conceptual perspective.

Authors:  U Busto; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

4.  Abuse of a commonly prescribed analgesic preparation.

Authors:  P Devenyi; J Rideout; J Schneiderman
Journal:  Can Med Assoc J       Date:  1985-08-15       Impact factor: 8.262

Review 5.  Metabolic diversity as a reason for unsuccessful detoxification from benzodiazepines: the rationale for serum BZD concentration monitoring.

Authors:  Anna Basińska-Szafrańska
Journal:  Eur J Clin Pharmacol       Date:  2021-01-03       Impact factor: 2.953

6.  Diazepam withdrawal seizures.

Authors:  G M Robinson; E M Sellers
Journal:  Can Med Assoc J       Date:  1982-04-15       Impact factor: 8.262

Review 7.  SARS-CoV-2 vaccines in development.

Authors:  Florian Krammer
Journal:  Nature       Date:  2020-09-23       Impact factor: 49.962

8.  Alcohol, barbiturate and benzodiazepine withdrawal syndromes: clinical management.

Authors:  E M Sellers
Journal:  CMAJ       Date:  1988-07-15       Impact factor: 8.262

9.  Kinetics of phenobarbital in normal subjects and epileptic patients.

Authors:  A J Wilensky; P N Friel; R H Levy; C P Comfort; S P Kaluzny
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Peripheral and lung resident memory T cell responses against SARS-CoV-2.

Authors:  Judith Grau-Expósito; Nerea Sánchez-Gaona; Núria Massana; Marina Suppi; Antonio Astorga-Gamaza; David Perea; Joel Rosado; Anna Falcó; Cristina Kirkegaard; Ariadna Torrella; Bibiana Planas; Jordi Navarro; Paula Suanzes; Daniel Álvarez-Sierra; Alfonso Ayora; Irene Sansano; Juliana Esperalba; Cristina Andrés; Andrés Antón; Santiago Ramón Y Cajal; Benito Almirante; Ricardo Pujol-Borrell; Vicenç Falcó; Joaquín Burgos; María J Buzón; Meritxell Genescà
Journal:  Nat Commun       Date:  2021-05-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.